Form 4: Cardinal Health Officer Sells Shares

Cardinal Health's Chief Legal/Compliance Officer, Jessica L. Mayer, reported the acquisition of restricted stock units and subsequent sales of common shares.

Summary

• Jessica L. Mayer, Chief Legal/Compliance Officer at Cardinal Health Inc. (CAH), reported transactions involving company securities.
• On August 15, 2025, Mayer was granted 9,358 restricted share units (RSUs) which will vest in three equal annual installments starting August 15, 2026.
• On August 15, 2025, 27,927 common shares were withheld at a price of $150.22 to cover tax obligations related to the vesting of 12,969 RSUs and 49,994 performance share units.
• On August 19, 2025, Mayer sold 4,345 common shares at a weighted average price of $148.08, with prices ranging from $147.46 to $148.45.
• On August 19, 2025, Mayer sold an additional 33,333 common shares at a weighted average price of $148.91, with prices ranging from $148.46 to $149.43.
• Also on August 19, 2025, Mayer sold 400 common shares at a weighted average price of $149.52, with prices ranging from $149.50 to $149.52.
• Following these transactions, Mayer's direct beneficial ownership of Cardinal Health common shares decreased from 114,462 to 48,457.

Sentiment

Score: 5

Explanation: While there's a significant sale of shares by an insider, a portion is for tax withholding, and the executive also received a new RSU grant. This is a routine disclosure of executive compensation and liquidity management, not necessarily indicative of negative sentiment towards the company's future.

Positives

• Grant of 9,358 restricted share units (RSUs) to the Chief Legal/Compliance Officer, aligning executive incentives with long-term company performance.

Negatives

• Significant sale of 66,005 common shares by the Chief Legal/Compliance Officer, including 27,927 shares for tax withholding and 38,078 shares through open market sales.
• The sales occurred at prices ranging from $147.46 to $149.52, indicating a reduction in direct equity exposure by a key executive.

Risks

• NA

Future Outlook

The 9,358 restricted share units granted to the Chief Legal/Compliance Officer are scheduled to vest in three equal annual installments beginning on August 15, 2026, indicating a future alignment of executive compensation with long-term performance.

Management Comments

• NA

Industry Context

NA

Comparison to Industry Standards

• NA

Related Party Transactions

• The filing details transactions by Jessica L. Mayer, Chief Legal/Compliance Officer, involving the acquisition of restricted share units and the sale of common shares, which constitute related party dealings.

Stakeholder Impact

• Shareholders may observe a reduction in direct equity ownership by a key executive, which could be interpreted in various ways, though a portion of sales is for tax purposes.
• Employees may see the RSU grant as a standard component of executive compensation, aligning leadership incentives with long-term company performance.

Next Steps

• The granted restricted share units will vest in three equal annual installments beginning on August 15, 2026.

Key Dates

Recommendation

This Form 4 filing details routine insider transactions, including the grant of restricted stock units and subsequent sales of common shares, some for tax purposes. While the net effect is a decrease in direct beneficial ownership, such transactions are common for executives managing their compensation and liquidity, often pre-planned. It does not provide sufficient new fundamental information to warrant a strong buy or sell recommendation, thus a "hold" stance is appropriate as investors should look to broader company performance and market conditions.

Keywords

Cardinal Health, CAH, SEC Form 4, Insider Trading, Stock Sales, Restricted Stock Units, Executive Compensation, Beneficial Ownership, Jessica L. Mayer, Chief Legal/Compliance Officer